You are here

Robert Coury

Mylan's Robert Coury returns to exec chairman role amid pandemic, delayed merger

Beckers Hospital Review

Thu, 04/16/20 - 11:07 am

The EpiPen maker’s chairman earned more than $97 million last year — and investors aren’t happy

Washington Post, DC

Sun, 06/25/17 - 06:21 pm

Mylan's Coury caps a year of controversy with $97M exit-pay package

Fierce Pharma

Tue, 05/2/17 - 11:20 am

Mylan says CEO Coury to step down; shares rise

Reuters

Wed, 10/26/11 - 11:04 am